 |
|
Preoperative vs Postoperative Initiation of Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients Undergoing Elective Hip Replacement
Russell D. Hull, MBBS, MSc;
Rollin F. Brant, PhD;
Graham F. Pineo, MD;
Paul D. Stein, MD;
Gary E. Raskob, MSc;
Karen A. Valentine, MD, PhD
Arch Intern Med. 1999;159:137-141.
Background Although preoperative and postoperative initiation of prophylaxis for deep vein thrombosis (DVT) with low-molecular-weight heparin (LMWH) are effective, the relative effectiveness and safety of these approaches is unknown. In the absence of a published definitive level 1 trial addressing this question, a meta-analysis is appropriate.
Objective To report a meta-analysis comparing preoperative with postoperative initiation of prophylaxis of DVT in patients undergoing elective hip replacement.
Methods Relevant trials were identified, and potential biases in the meta-analysis were minimized by analyzing all rigorously performed randomized trials that met all of the following criteria for conduct of the trial: (1) double-blind design, (2) objective documentation of the frequencies of DVT by ascending contrast venography, (3) venography performed before or at the time of discharge from the hospital, (4) initiation of the same LMWH preoperatively or postoperatively in dosages shown to be effective, (5) compliance with the criteria for a level 1 trial, and (6) objective documentation of major and minor bleeding according to strict criteria.
Results Treatment with LMWH initiated preoperatively was associated with a DVT frequency of 10.0% compared with a frequency of 15.3% when the LMWH was initiated postoperatively (P=.02, Fisher exact test). Major bleeding was less frequent in patients receiving preoperatively initiated LMWH than in patients receiving postoperatively initiated LMWH (0.9%, vs 3.5%; P=.01, Fisher exact test).
Conclusions Our findings support the need for a randomized comparison of preoperative and postoperative initiation of pharmacological prophylaxis of DVT. Such a trial would resolve the divergent practices for DVT prophylaxis between Europe and the North American countries, the United States and Canada, and would affect the treatment for thousands of patients on both continents.
From the Thrombosis Research Unit, Foothills Hospital, University of Calgary, Calgary, Alberta (Drs Hull, Brant, Pineo, and Valentine); the Cardiac Wellness Unit, Henry Ford Hospital, Detroit, Mich (Dr Stein); and the Departments of Medicine and Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City (Dr Raskob).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Risk Factors for Venous Thromboembolism After Lung Transplantation
Yegen et al.
Chest 2007;132:547-553.
ABSTRACT
| FULL TEXT
Preventing deep vein thrombosis in hospital inpatients
Cayley
BMJ 2007;335:147-151.
FULL TEXT
Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
Dunn et al.
Med Decis Making 2005;25:387-397.
ABSTRACT
Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Geerts et al.
Chest 2004;126:338S-400S.
ABSTRACT
| FULL TEXT
New Pentasaccharides for the Prophylaxis of Venous Thromboembolism: Clinical Studies
Turpie et al.
Chest 2003;124:371S-378S.
ABSTRACT
| FULL TEXT
Hospital Guidelines for Use of Low-Molecular-Weight Heparins
Nutescu et al.
The Annals of Pharmacotherapy 2003;37:1072-1081.
ABSTRACT
| FULL TEXT
Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Dunn and Turpie
Arch Intern Med 2003;163:901-908.
ABSTRACT
| FULL TEXT
Preoperative or Postoperative Start of Prophylaxis for Venous Thromboembolism With Low-Molecular-Weight Heparin in Elective Hip Surgery?
Strebel et al.
Arch Intern Med 2002;162:1451-1456.
ABSTRACT
| FULL TEXT
Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip Arthroplasty: A Systematic Review
Hull et al.
Arch Intern Med 2001;161:1952-1960.
ABSTRACT
| FULL TEXT
Prevention of Venous Thromboembolism: Recommendations Based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy
Haas
CLIN APPL THROMB HEMOST 2001;7:171-177.
ABSTRACT
Prevention of Venous Thromboembolism
Geerts et al.
Chest 2001;119:132S-175S.
FULL TEXT
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients: A Double-blind, Randomized Comparison
Hull et al.
Arch Intern Med 2000;160:2199-2207.
ABSTRACT
| FULL TEXT
Evidence-Based Evaluation of Preoperative vs Postoperative Use of Low-Molecular-Weight Heparin in Preventing Deep Vein Thrombosis in Elective Hip Surgery
Ghosh et al.
Arch Intern Med 1999;159:1622-1623.
FULL TEXT
|
